Terano, Chikako <br/><br/>
Practical issues in using eculizumab for children with atypical haemolytic uraemic syndrome in the acute phase: A review of four patients.  [electronic resource] 

 -  Nephrology (Carlton, Vic.)  Jun 2018 
 - 539-545 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1440-1797 
<br/><br/><label>Standard No.: </label>10.1111/nep.13054  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Age Factors<br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Atypical Hemolytic Uremic Syndrome--diagnosis<br/>Child, Preschool<br/>Complement Inactivating Agents--administration & dosage<br/>Drug Administration Schedule<br/>Drug Eruptions--etiology<br/>Electronic Health Records<br/>Female<br/>Humans<br/>Immunocompromised Host<br/>Infant<br/>Male<br/>Meningococcal Infections--chemically induced<br/>Opportunistic Infections--chemically induced<br/>Remission Induction<br/>Retrospective Studies<br/>Risk Factors<br/>Time Factors<br/>Tokyo<br/>Treatment Outcome